The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Perils and pitfalls of long-term effects of proton pump inhibitors
Abstract
This review summarizes the literature regarding long-term adverse effects of proton pump inhibitors (PPIs). A PubMed search (1966 to February 2013) for English language studies was conducted using key terms PPI: omeprazole, esomeprazole, pantoprazole, lansoprazole, dexlansoprazole, rabeprazole, pneumonia, Clostridium difficile, osteoporosis, risk of fractures, thrombocytopenia, rhabdomyolysis, anemia, iron deficiency, hypomagnesemia, vitamin B₁₂ and nephritis. The risk of pneumonia was increased 27-39% in short-term use of PPIs in three meta-analyses. C. difficile infections were also associated with the use of PPIs (odds ratio: 2.15; 95% CI: 1.81-2.55; p < 0.00001). This effect appears to be dose related. The US FDA has recently issued a warning regarding fractures and the impaired magnesium absorption associated with the use of PPI. Thrombocytopenia, iron deficiency, vitamin B12 deficiency, rhabdomyolysis and acute interstitial nephritis have also been reported with the use of PPIs. There is mounting evidence that PPIs are associated with serious adverse effects. Practitioners should be vigilant and counsel patients accordingly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While PPIs are generally considered safe and well tolerated, they have been associated with adverse events, especially in the long term.”
From Proton pump inhibitors for functional dyspepsia (2017) · cites this paper as Wilhelm 2013
Citations
Cites
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,006
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
Yang, Y.-X., Lewis, J. D., Epstein, S., & Metz, D. C. (2006) · JAMA · doi:10.1001/jama.296.24.2947 · Cited by 1,214
Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians.
Huerta-Alardin, A. L., Varón, J., & Marik, P. E. (2004) · Critical Care · doi:10.1186/cc2978 · Cited by 1,078
Stadtman, T. C. (1971) · Science · doi:10.1126/science.171.3974.859 · Cited by 541
Iatrogenic Gastric Acid Suppression and the Risk of Nosocomial Clostridium difficile Infection
Howell, M. D. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.89 · Cited by 437
Use of proton pump inhibitors and risk of osteoporosis-related fractures
Targownik, L. E., Lix, L. M., Metge, C. J., Prior, H. J., Leung, S., & Leslie, W. D. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071330 · Cited by 436
O’Connell, M. B., Madden, D. M., Murray, A. M., Heaney, R. P., & Kerzner, L. J. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.02.007 · Cited by 405
Canani, R. B., Cirillo, P., Roggero, P., Romano, C., Malamisura, B., Terrin, G., Passariello, A., Manguso, F., Morelli, L., Guarino, A., et al. (2006) · Pediatrics · doi:10.1542/peds.2005-1655 · Cited by 398
Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis
Eom, C.-S., Jeon, C. Y., Lim, J.-W., Cho, E.-G., Park, S. M., & Lee, K.-S. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.092129 · Cited by 393
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0021-7 · Cited by 372
Gray, S. L. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.94 · Cited by 329
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Proton-Pump Inhibitors and Hypomagnesemic Hypoparathyroidism
Epstein, M., McGrath, S., & Law, F. (2006) · New England Journal of Medicine · doi:10.1056/nejmc066308 · Cited by 302
Proton Pump Inhibitors and Risk of Fractures: A Meta-Analysis of 11 International Studies
Yu, E. W., Bauer, S. R., Bain, P. A., & Bauer, D. C. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.01.007 · Cited by 295
Ngamruengphong, S., Leontiadis, G. I., Radhi, S., Dentino, A., & Nugent, K. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.113 · Cited by 281
Corley, D. A., Kubo, A., Zhao, W., & Quesenberry, C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.055 · Cited by 271
Omeprazole Therapy Causes Malabsorption of Cyanocobalamin (Vitamin B12)
Marcuard, S. P., Albernaz, L., & Khazanie, P. G. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00006 · Cited by 251
Severe hypomagnesaemia in long‐term users of proton‐pump inhibitors
Cundy, T., & Dissanayake, A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03194.x · Cited by 234
A Case Series of Proton Pump Inhibitor–Induced Hypomagnesemia
Hoorn, E. J., van der Hoek, J., de Man, R. A., Kuipers, E. J., Bolwerk, C., & Zietse, R. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.11.019 · Cited by 233
Khalili, H., Huang, E. S., Jacobson, B. C., Camargo, C. A., Feskanich, D., & Chan, A. T. (2012) · BMJ · doi:10.1136/bmj.e372 · Cited by 224
Review article: proton pump inhibitors and bacterial overgrowth
WILLIAMS, C., & McCOLL, K. E. L. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02707.x · Cited by 221
Safety of Proton Pump Inhibitor Exposure
Yang, Y., & Metz, D. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.023 · Cited by 219
Infectious Disease Hospitalizations in the United States
Christensen, K. L. Y., Holman, R. C., Steiner, C. A., Sejvar, J. J., Stoll, B. J., & Schonberger, L. B. (2009) · Clinical Infectious Diseases · doi:10.1086/605562 · Cited by 219
Deshpande, A., Pant, C., Pasupuleti, V., Rolston, D. D. K., Jain, A., Deshpande, N., Thota, P., Sferra, T. J., & Hernandez, A. V. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.09.030 · Cited by 213
Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older Adults
Yu, E. W., Blackwell, T., Ensrud, K. E., Hillier, T. A., Lane, N. E., Orwoll, E., & Bauer, D. C. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9170-1 · Cited by 210
Inappropriate prescribing of proton pump inhibitors in primary care
Batuwitage, B. T., Kingham, J. G. C., Morgan, N. E., & Bartlett, R. L. (2007) · Postgraduate Medical Journal · doi:10.1136/pgmj.2006.051151 · Cited by 206
Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis
Hutchinson, C., Geissler, C. A., Powell, J. J., & Bomford, A. (2007) · Gut · doi:10.1136/gut.2006.108613 · Cited by 205
Proton Pump Inhibitors and Acute Interstitial Nephritis
Geevasinga, N., Coleman, P. L., Webster, A. C., & Roger, S. D. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.11.004 · Cited by 188
Proton pump inhibitors in GORDAn overview of their pharmacology, efficacy and safety
Savarino, V., Di Mario, F., & Scarpignato, C. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2008.09.016 · Cited by 187
Overuse of proton pump inhibitors
Naunton, M., Peterson, G. M., & Bleasel, M. D. (2000) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2000.00312.x · Cited by 183
Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors
Kaye, J. A., & Jick, H. (2008) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.8.951 · Cited by 182
Termanini, B., Gibril, F., Sutliff, V. E., Yu, F., Venzon, D. J., & Jensen, R. T. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00087-4 · Cited by 176
Meta‐analysis: proton pump inhibitor use and the risk of community‐acquired pneumonia
JOHNSTONE, J., NERENBERG, K., & LOEB, M. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04284.x · Cited by 163
Systematic review: proton pump inhibitor‐associated acute interstitial nephritis
SIERRA, F., SUAREZ, M., REY, M., & VELA, M. F. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03407.x · Cited by 160
Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series
Mackay, J., & BLADON, P. T. (2010) · QJM · doi:10.1093/qjmed/hcq021 · Cited by 157
Proton pump inhibitors and acute interstitial nephritis: Report and analysis of 15 cases
Simpson, I. J., Marshall, M. R., Pilmore, H., MANLEY, P., Williams, L. C., THEIN, H., & Voss, D. (2006) · Nephrology · doi:10.1111/j.1440-1797.2006.00651.x · Cited by 155
Long‐term use of proton pump inhibitors and vitamin B12 status in elderly individuals
den Elzen, W. P. J., Groeneveld, Y., de Ruijter, W., Souverijn, J. H. M., le Cessie, S., Assendelft, W. J., & Gussekloo, J. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03601.x · Cited by 138
Giuliano, C. A., Wilhelm, S. M., & Kale-Pradhan, P. B. (2012) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.20 · Cited by 136
Self-citationAcute interstitial nephritis due to omeprazole
Ruffenach, S. J., Siskind, M. S., & Lien, Y.-H. H. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90181-a · Cited by 133
Hypomagnesemia Induced by Several Proton-Pump Inhibitors
Broeren, M. A. C., Geerdink, E. A. M., Vader, H. L., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00016 · Cited by 127
Use of Acid-Suppressive Drugs and Risk of Fracture: A Meta-analysis of Observational Studies
Eom, C.-S., Park, S.-M., Myung, S., Yun, J. M., & Ahn, J. S. (2011) · The Annals of Family Medicine · doi:10.1370/afm.1243 · Cited by 126
Role of Gastric Acid in Food Iron Absorption
Skikne, B., Lynch, S. R., & Cook, J. D. (1981) · Gastroenterology · doi:10.1016/s0016-5085(81)80013-3 · Cited by 126
Increase in Vertebral Fracture Risk in Postmenopausal Women Using Omeprazole
Roux, C., Briot, K., Gossec, L., Kolta, S., Blenk, T., Felsenberg, D., Reid, D. M., Eastell, R., & Glüer, C. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9188-4 · Cited by 123
Serum Iron, Ferritin, and Vitamin B12 During Prolonged Omeprazole Therapy
Koop, H., & Bachem, M. G. (1992) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199206000-00005 · Cited by 119
Hirschowitz, B. I., Worthington, J. L., & Mohnen, J. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03658.x · Cited by 115
Hypomagnesaemia due to use of proton pump inhibitors--a review.
Kuipers, M. T., Thang, H. D., & Arntzenius, A. B. (2009) · PubMed · Cited by 112
Stewart, Termanini, Sutliff, Serrano, Yu, Gibril, & Jensen (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00274.x · Cited by 112
Torpey, N., Barker, T., & Ross, C. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh137 · Cited by 112
Proton pump inhibitors and severe hypomagnesaemia
Cundy, T., & Mackay, J. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32833ff5d6 · Cited by 112
Proton pump inhibitor‐induced acute interstitial nephritis
Härmark, L., van der Wiel, H. E., de Groot, M., & van Grootheest, A. C. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02927.x · Cited by 108
Effect of Hydrochloric Acid on Iron Absorption
Schade, S. G., Cohen, R. J., & Conrad, M. E. (1968) · New England Journal of Medicine · doi:10.1056/nejm196809262791302 · Cited by 107
Goodman & Gilman's the Pharmacological Basis of Therapeutics 12 th Edition 2011
Shetty, P. A., & Dharia, H. V. (2015) · Indian Practitioner · Cited by 107
Omeprazole and refractory hypomagnesaemia
Shabajee, N., Lamb, E. J., Sturgess, I., & Sumathipala, R. W. (2008) · BMJ · doi:10.1136/bmj.39505.738981.be · Cited by 103
Effect of Omeprazole on Oral Iron Replacement in Patients with Iron Deficiency Anemia
Sharma, V. R., Brannon, M. A., & Carloss, E. A. (2004) · Southern Medical Journal · doi:10.1097/01.smj.0000110405.63179.69 · Cited by 102
Hypochlorhydric stomach: a risk condition for calcium malabsorption and osteoporosis?
Sipponen, P., & Härkönen, M. (2009) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365520903434117 · Cited by 95
Uses of proton pump inhibitors and hypomagnesemia
Gau, J., Yang, Y., Chen, R., & Kao, T. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3224 · Cited by 90
Appropriateness of treatment recommendations for PPI in hospital discharge letters
Ahrens, D., Chenot, J., Behrens, G., Grimmsmann, T., & Kochen, M. M. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0871-9 · Cited by 85
Role of hydrochloric acid in iron absorption
Jacobs, P. B., Bothwell, T. H., & Charlton, R. W. (1964) · Journal of Applied Physiology · doi:10.1152/jappl.1964.19.2.187 · Cited by 85
Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
Clark, D. W. J., & Strandell, J. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0131-1 · Cited by 82
Severe Hypomagnesemia During Long-term Treatment With a Proton Pump Inhibitor
Regolisti, G., Cabassi, A., Parenti, E., Maggiore, U., & Fiaccadori, E. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.03.013 · Cited by 79
Continuation of Proton Pump Inhibitors from Hospital to Community
Grant, K., Al-Adhami, N., Tordoff, J. M., et al. (2006) · Pharmacy World & Science · doi:10.1007/s11096-006-9028-4 · Cited by 76
Rozgony, N. R., Fang, C., Kuczmarski, M. F., & Bob, H. (2010) · Journal of Nutrition for the Elderly · doi:10.1080/01639360903574734 · Cited by 74
Acute Interstitial Nephritis Due to Pantoprazole
Ra, A., & Tobe, S. W. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d085 · Cited by 69
Proton pump inhibitors therapy and risk of hip fracture
Ye, X., Liu, H., Wu, C., et al. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328348a56a · Cited by 65
Long-Term Proton Pump Inhibitor Use in Children: A Retrospective Review of Safety
Tolia, V. K., & Boyer, K. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9880-7 · Cited by 65
Hermos, J. A., Young, M., Fonda, J. R., GAGNON, D. R., Fiore, L. D., & Lawler, E. V. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir767 · Cited by 61
Hypomagnesemia and Proton Pump Inhibitors
Furlanetto, T. W. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.199 · Cited by 60
Proton pump-inhibiting drugs, calcium homeostasis, and bone health
Wright, M. J., Proctor, D. D., Insogna, K. L., & Kerstetter, J. E. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00015.x · Cited by 59
Metz, D. C., Sostek, M. B., Ruszniewski, P. B., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01509.x · Cited by 58
Rabeprazole‐induced acute interstitial nephritis
Geevasinga, N., COLEMAN, P. L., & Roger, S. D. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00365.x · Cited by 50
Pantoprazole-lnduced Thrombocytopenia
Watson, T. D., Stark, J. E., & Vesta, K. S. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g384 · Cited by 43
Neale, G. (1990) · Gut · doi:10.1136/gut.31.1.59 · Cited by 32
Proton-pump inhibitors in acid-related diseases
Berardi, R. R., & Welage, L. S. (1998) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/55.21.2289 · Cited by 32
CASE REPORT: Iron Deficiency Anemia: Induced by Long-Term Ingestion of Omeprazole
Khatib, M., RAHIM, O., Kania, R. J., & Molloy, P. J. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1020540916482 · Cited by 28
Pantoprazole-induced acute interstitial nephritis
Moore, I., Sayer, J. A., Nayar, A., Ahmed, S., & Tapson, J. S. (2004) · Journal of Nephrology · doi:10.1093/joneph/17.4.580 · Cited by 27
Intravenous Proton Pump Inhibitors
Bardou, M., Martin, J. E., & Barkun, A. N. (2009) · Drugs · doi:10.2165/00003495-200969040-00004 · Cited by 26
Recurrent Hypomagnesemia With Proton-Pump Inhibitor Rechallenge
Quasdorff, M., Mertens, J., Dinter, J., & Steffen, H. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-6-201109200-00022 · Cited by 26
The Effect of Omeprazole on Gastric Acidity and the Absorption of Liver Cobalamins
Kittang, E., Aadland, E., Schjønsby, H., & Rohss, K. M. (1987) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528708991873 · Cited by 24
Acute interstitial nephritis secondary to esomeprazole
Geevasinga, N., Kairaitis, L., Rangan, G. K., & Coleman, P. L. (2005) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2005.tb06675.x · Cited by 24
Rhabdomyolysis associated with omeprazole
Nozaki, M., Suzuki, T., & Hirano, M. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-003-1231-7 · Cited by 19
Pantoprazole-induced thrombocytopenia
Miller, J. L., Gormley, A. K., & Johnson, P. N. (2009) · The Indian Journal of Pediatrics · doi:10.1007/s12098-009-0224-9 · Cited by 18
Esomeprazole-induced rhabdomyolysis in a patient with heart failure
Tröger, U., Reiche, I., Jepsen, M. S., Huth, C., & Bode‐Böger, S. M. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1854-0 · Cited by 18
Acute allergic interstitial nephritis after use of pantoprazole
Ricketson, J., Kimel, G., Spence, J. D., & Weir, R. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.080456 · Cited by 18
The prevalence of pantoprazole associated thrombocytopenia in a community hospital
Dotan, E., Katz, R. M., Bratcher, J., Wasserman, C., Liebman, M., Panagopoulos, G., & Spaccavento, C. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.13.2025 · Cited by 16
McGowan, B., Bennett, K., & Barry, M. G. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1972 · Cited by 16
Multiple organ failure related to pantoprazole
Yusoff, I. F., NAIRN, P., & MORGAN, C. A. (1999) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1999.tb00796.x · Cited by 12
Intravenous proton pump inhibitors.
Baker, D. E. (2006) · PubMed · Cited by 11
Acute interstitial nephritis related to lansoprazole administration.
José, J., Saravu, K., Khera, K., Jimmy, B., & Shastry, B. A. (2008) · PubMed · Cited by 9
Kim, M. J., Heim, M. H., & Mayr, M. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp751 · Cited by 8
Krishnamurthy, M., Snyder, R., & Bachurina, M. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02409.x · Cited by 6
Letters: Omeprazole and Vitamin B12
Lavy, N. W. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-1-199407010-00021 · Cited by 3
Multiple organ failure and pantoprazole
DEHESA, C., & KASSEL, G. (2000) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.2000.tb04373.x · Cited by 3
Research works printed but not linked: 7
- Theodorou, 2010, Am. J. Pharm. Benefits, 2, 327
- Baker, 2006, Rev. Gastroenterol. Disord., 6, 22
- Kuipers, 2009, Neth. J. Med., 67, 169
- Zlabek, 2002, Ann. Pharmacother., 36, 809, 10.1345/aph.1A303 · doi:10.1345/aph.1a303
- Conrad, 1987, In: Physiology of the Gastrointestinal Tract, 2nd Edition.
- Moore, 2004, J. Nephrol., 17, 580
- Jose, 2008, J. Pak. Med. Assoc., 58, 206
Cited by
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
Lazarus, B., Chen, Y., Wilson, F. P., Sang, Y., Chang, A. R., Coresh, J., & Grams, M. E. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7193 · Cited by 729
Berger, M. M., Shenkin, A., Schweinlin, A., Amrein, K., Augsburger, M., Biesalski, H.-K., Bischoff, S. C., Casaer, M. P., Gundogan, K., Lepp, H.-L., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.02.015 · Cited by 615
Biomarkers and Algorithms for the Diagnosis of Vitamin B12 Deficiency
Hannibal, L., Lysne, V., Bjørke-Monsen, A.-L., Behringer, S., Grünert, S. C., Spiekerkoetter, U., Jacobsen, D. W., & Blom, H. J. (2016) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2016.00027 · Cited by 355
Review article: the nutritional and pharmacological consequences of obesity surgery
Stein, J., Stier, C., Raab, H., & Weiner, R. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12872 · Cited by 256
Proton pump inhibitors for functional dyspepsia
Pinto-Sanchez, M. I., Yuan, Y., Hassan, A., Bercik, P., & Moayyedi, P. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011194.pub3 · Cited by 195
Metadata
- Authors
- Wilhelm, S. M., Rjater, R. G., & Kale-Pradhan, P. B.
- Venue
- Expert Review of Clinical Pharmacology
- Publisher
- Informa UK Limited
- Published
- 2013-07
- Volume
- 6
- Issue
- 4
- Pages
- 443-451
- ISSN
- 1751-2433
- 1751-2441
- Cited by
- 104
- References
- 92
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.